- Home
- SNY vs NCMI Comparison
SNY vs NCMI Comparison
Compare SNY & NCMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- NCMI
- Stock Information
- Founded
- SNY 1994
- NCMI 2005
- Country
- SNY France
- NCMI United States
- Employees
- SNY N/A
- NCMI N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- NCMI Advertising
- Sector
- SNY Health Care
- NCMI Consumer Discretionary
- Exchange
- SNY Nasdaq
- NCMI Nasdaq
- Market Cap
- SNY 116.1B
- NCMI 434.8M
- IPO Year
- SNY N/A
- NCMI 2007
- Fundamental
- Price
- SNY $50.52
- NCMI $4.25
- Analyst Decision
- SNY Buy
- NCMI Strong Buy
- Analyst Count
- SNY 4
- NCMI 4
- Target Price
- SNY $61.50
- NCMI $7.00
- AVG Volume (30 Days)
- SNY 3.9M
- NCMI 450.4K
- Earning Date
- SNY 10-24-2025
- NCMI 10-30-2025
- Dividend Yield
- SNY 3.16%
- NCMI 2.75%
- EPS Growth
- SNY 118.56
- NCMI N/A
- EPS
- SNY 8.65
- NCMI N/A
- Revenue
- SNY $53,714,621,258.00
- NCMI $235,300,000.00
- Revenue This Year
- SNY $1.40
- NCMI $5.40
- Revenue Next Year
- SNY $6.67
- NCMI $13.88
- P/E Ratio
- SNY $5.85
- NCMI N/A
- Revenue Growth
- SNY 15.65
- NCMI 13.34
- 52 Week Low
- SNY $44.62
- NCMI $4.03
- 52 Week High
- SNY $60.12
- NCMI $7.60
- Technical
- Relative Strength Index (RSI)
- SNY 61.12
- NCMI 46.45
- Support Level
- SNY $48.54
- NCMI $4.03
- Resistance Level
- SNY $49.43
- NCMI $4.28
- Average True Range (ATR)
- SNY 0.93
- NCMI 0.17
- MACD
- SNY 0.21
- NCMI -0.02
- Stochastic Oscillator
- SNY 91.76
- NCMI 56.19
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About NCMI National CineMedia Inc.
National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.